Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Curcumin-based nanotherapeutics - Laila Pharmaceuticals

Next Previous
Search
Drug Profile

Curcumin-based nanotherapeutics - Laila Pharmaceuticals

Alternative Names: LP-001-09; LP-002-09; LP-004-09; LP-005-09; LP-013-09; LPCVD; LPD-1050; LPG-1030-I; LPG-1030-S; LPMD; LPO-1010-AM; LPO-1010-CA; LPO-1010-CSR; LPO-1010-DR; LPO-1010-UV

Latest Information Update: 24 Mar 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Laila Pharmaceuticals
  • Class Analgesics; Anti-ischaemics; Antianaemics; Antihistamines; Antivirals; Catechols; Chemopreventatives; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Angiogenesis inhibitors; Antioxidants; Cyclo-oxygenase 2 inhibitors; HIV integrase inhibitors; Immunosuppressants; Mast cell stabilisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Age-related macular degeneration; Allergic conjunctivitis; Alzheimer's disease; Cardiovascular disorders; Cataracts; Central serous chorioretinopathy; Diabetes mellitus; Diabetic retinopathy; HIV infections; Inflammatory bowel diseases; Irritable bowel syndrome; Osteoarthritis; Psoriasis; Stomatitis; Uveitis

Most Recent Events

  • 24 Mar 2023 Discontinued - Phase-I for Age-related macular degeneration in India (Ophthalmic)
  • 24 Mar 2023 Discontinued - Phase-I for Cataracts in India (Ophthalmic)
  • 24 Mar 2023 Discontinued - Phase-I for Psoriasis in India (Topical)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top